Browsing by Author "Gultekin, M."
Now showing 1 - 15 of 15
- Results Per Page
- Sort Options
Item Adjuvant Radiotherapy in Cervical Cancer Patients: TROD Gynecologic Group Study(2020) Gultekin, M.; Esen, C. S. Beduk; Balci, B.; Alanyali, S.; Yildirim, B. Akkus; Ergen, S. A.; Sahinler, I.; Cetin, I. Alsan; Onal, C.; Yildiz, F.; Ozsaran, Z.; 0000-0002-2742-9021; D-5195-2014Item Adjuvant Radiotherapy in Clear Cell and Serous Papillary Endometrial Cancer(2015) Sari, S. Yuce; Gultekin, M.; Yuce, K.; Ayhan, A.; Altundag, O.; Kars, A.; Turker, A.; Ocalan, R.; Hurmuz, P.; Yildiz, F.; 0000-0003-0197-6622; W-9219-2019; ABX-1273-2022; AAJ-5802-2021Item Adjuvant Small Pelvic Radiation Therapy in Cervical Cancer Patients With Minor Risk Factors(2016) Sari, S. Yuce; Guler, O. C.; Gultekin, M.; Onal, C.; Yildiz, F.; 0000-0001-6908-3412; ABX-1273-2022; AAC-5654-2020; HOC-5611-2023Item Centralization of mammography reporting with mobile trucks: Turkish experience(2018) Gultekin, M.; Ozturk, C.; Karaca, S.; Boztaş, G.; Turan, S.H.; Dundar, S.; Hacikamiloglu, E.; Araz, L.; Murtuza, K.; Keskinkilic, B.Screening via mammography is a complex process to be implemented. Objective: To report the initial results and the effectiveness of newly implemented Turkey's population based breast cancer screening program performed for 40–69 years old women; and effectiveness of the newly implemented out-sourcing mobile trucks and national central report center. The study is conducted prospectively in one year (March 2016–March 2017) in all 81 provinces of Turkey. Mammography images were transferred via on-line web based system to the central reporting center. BI-RADS Scores and KETEM models (Mobile vs. Stationary) were the parameters were compared. In total mammography images of 414.802 patients were transferred from 155 KETEMs to the central reporting center. From these patients; 95.872 (23,1%) were aged between 40 and 44. Among all images, 21.999 (5,3%) were BI-RADS 0-4-5, 391.123 (94,3%) were BI-RADS 1–2. Totally recall rate of the national reporting center was 5.3%. Number of patients screened per day were significantly higher in out-sourcing mobile trucks compared to stationary KETEMs (31.8 vs. 8.9; p < 0.05). This is the first and the largest breast cancer screening study which results of a population based mammography screening for 40–69 years old women are evaluated at the same time with the evaluation of the efficacy of newly implemented centralized reporting center and the mobile screening trucks in comparison with stationary cancer screening centers. According to the initial results; Turkey's newly implemented population based breast cancer screening system seems to be feasible and effective. © 2018 The AuthorsItem The Clinical Outcomes Of Breast Cancer Lung Metastasis Treated With Stereotactic Body Radiotherapy(2022) Guler, O. C.; Sari, S. Yuce; Gultekin, M.; Yildiz, F.; Onal, C.Item The impact of lymph node ratio in patients with stage IIIC endometrial carcinoma(2021) Onal, C.; Sari, S. Yuce; Yavas, G.; Guler, O. C.; Yigit, E.; Oymak, E.; Gultekin, M.; Yildiz, F.Item Patterns of Recurrence and Survival Rates in Endometrial Cancer According to ESMO-ESGO-ESTRO Risk Classification(2018) Sari, S. Yuce; Gultekin, M.; Rahatli, S.; Altundag, O.; Turker, A.; Kars, A.; Yuce, K.; Ayhan, A.; Ozyigit, G.; Yildiz, F.; 0000-0003-3163-7429; 0000-0003-0197-6622; AAJ-3047-2021; W-9219-2019Item Radiation Therapy Outcomes After Skin-Sparing Mastectomy and Implant-Based Breast Reconstruction(2016) Sari, S. Yuce; Kotek, A.; Gultekin, M.; Yildirim, B. Akkus; Onal, C.; Ozyigit, G.; Gurkaynak, M.; Yildiz, F.; https://orcid.org/0000-0001-6661-4185; V-5717-2017; HOC-5611-2023Item SATEN III - Splitting Adjuvant Treatment into Subgroups Of Stage III Endometrioid Endometrial Cancers: An International, Multicenter Study(2019) Kahramanoglu, I; Meydanli, M. M.; Taranenka, S.; Ayhan, A.; Salman, C.; Sanci, M.; Demirkiran, F.; Ortac, F.; Haidopoulos, D.; Sukhin, V.; Kaidarova, D.; Stepanyan, A.; Farazaneh, F.; Aliyev, S.; Ulrikh, E.; Kurdiani, D.; Yalcin, I.; Mavrichev, S.; Akilli, H.; Sari, M. E.; Pletnev, A.; Aslan, K.; Bese, T.; Kairbayev, M.; Vlachos, D.; Gultekin, M.; AAJ-5802-2021Item Stage Ib Endometrial Cancer: The Role of Number of Dissected Lymph Nodes(2015) Sari, S. Yuce; Gultekin, M.; Yazici, G.; Tulunay, G.; Boran, N.; Dursun, P.; Gungor, T.; Yuce, K.; Ortac, F.; Ayhan, A.; Yildiz, F.Item Stage II Endometrial Cancer: External Pelvic Radiation Therapy Alone or External Pelvic Radiation Therapy With Brachytherapy(2015) Sari, S. Yuce; Gultekin, M.; Dursun, P.; Salman, C.; Ozgul, N.; Ortac, F.; Yuce, K.; Ayhan, A.; Yildiz, F.Item Treatment Outcomes of Breast Cancer Lung Metastasis Treated with Stereotactic Body Radiotherapy(2020) Guler, O. C.; Sari, S. Y.; Gultekin, M.; Yildirim, B. A.; Ozyilkan, O.; Yildiz, F.; Onal, C.; 0000-0001-6661-4185; V-5717-2017; ABX-1273-2022; HOC-5611-2023Item Treatment Outcomes of Definitive or Postoperative Radiotherapy in Elderly Cervical Cancer Patients(2015) Guler, O. C.; Sari, S. Y.; Birge, S. D.; Gultekin, M.; Yildiz, F.; Onal, C.; 0000-0002-4221-4459; 0000-0001-6908-3412; AAQ-5865-2020; AAC-5654-2020; HOC-5611-2023; ABX-1273-2022Item The Utility of Dissected Lymph Node Number and Lymph Node Metastasis Ratio In Stage IIIC Endometrium Adenocarcinoma: A Multicentric Analysis(2018) Yildirim, B. Akkus; Onal, C.; Sari, S. Yuce; Yavas, G.; Gultekin, M.; Guler, O. C.; Yildiz, F.; Akyurek, S.; https://orcid.org/0000-0001-6661-4185; V-5717-2017; HOC-5611-2023Item Validation of the ESMO-ESGO-ESTRO Consensus Conference Risk Grouping in Turkish Endometrial Cancer Patients Treated with Comprehensive Surgical Staging(2019) Gultekin, M.; Guler, O. C.; Sari, S. Yuce; Yildirim, B. Akkus; Mustafayev, T. Z.; Atalar, B.; Bolukbasi, Y.; Onal, H. C.; Celik, H.; Yuce, K.; Ayhan, A.; Yildiz, F.; 0000-0001-6908-3412; AAC-5654-2020